We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRND.WS
101
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$1.75M 0.01%
540,000
– –
GATE
102
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.62M 0.01%
150,000
– –
VNET
103
VNET Group
VNET
$2.09B
$1.36M 0.01%
650,000
– –
QTRX icon
104
Quanterix
QTRX
$190M
$1.06M ﹤0.01%
80,000
-391,000
-83% -$6.53M
FBRX icon
105
Forte Biosciences
FBRX
$1.57B
$972K ﹤0.01%
72,418
– –
MDGL icon
106
Madrigal Pharmaceuticals
MDGL
$11.8B
$930K ﹤0.01%
3,319
– –
VEEV icon
107
Veeva Systems
VEEV
$37.4B
$663K ﹤0.01%
+3,622
New +$719K
SAGE
108
DELISTED
Sage Therapeutics
SAGE
$465K ﹤0.01%
42,800
– –
BPMC
109
DELISTED
Blueprint Medicines
BPMC
$431K ﹤0.01%
4,000
– –
TVRD
110
Tvardi Therapeutics
TVRD
$23.4M
$402K ﹤0.01%
43,229
– –
KRYS icon
111
Krystal Biotech
KRYS
$9.66B
$367K ﹤0.01%
2,000
– –
AXSM icon
112
Axsome Therapeutics
AXSM
$10.9B
$322K ﹤0.01%
4,000
– –
HCA icon
113
HCA Healthcare
HCA
$89.5B
$321K ﹤0.01%
1,000
– –
IMVT icon
114
Immunovant
IMVT
$8.25B
$317K ﹤0.01%
+12,000
New +$341K
GKOS icon
115
Glaukos
GKOS
$10.6B
$308K ﹤0.01%
2,600
– –
TMDX icon
116
Transmedics
TMDX
$2.91B
$301K ﹤0.01%
+2,000
New +$240K
LUNRW
117
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$299K ﹤0.01%
440,965
– –
MMSI icon
118
Merit Medical Systems
MMSI
$5.32B
$258K ﹤0.01%
3,000
– –
EHC icon
119
Encompass Health
EHC
$12.4B
$257K ﹤0.01%
3,000
– –
BTSG icon
120
BrightSpring Health Services
BTSG
$12.4B
$250K ﹤0.01%
22,000
– –
GMED icon
121
Globus Medical
GMED
$11.2B
$247K ﹤0.01%
+3,600
New +$215K
ARQT icon
122
Arcutis Biotherapeutics
ARQT
$3.18B
$242K ﹤0.01%
26,000
-1,754,000
-99% -$15.9M
HQY icon
123
HealthEquity
HQY
$8.75B
$241K ﹤0.01%
2,800
– –
MRUS
124
DELISTED
Merus
MRUS
$237K ﹤0.01%
+4,000
New +$194K
APLS
125
DELISTED
Apellis Pharmaceuticals
APLS
$230K ﹤0.01%
6,000
– –
3 4
5
6 7

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Farallon Capital Management held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Walt Disney worth $356M.

  • Farallon Capital Management's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Farallon Capital Management added most to Aon in Q2 2024, an estimated $368M increase.
  • Farallon Capital Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Farallon Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Farallon Capital Management opened 23 new positions and closed 30 in Q2 2024.
  • Farallon Capital Management's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.